Latest filing published 30 Apr 2026 for HCA Healthcare, Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Thomas F. Frist III, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in HCA Healthcare, Inc., Verisign Inc/ca and Science Applications International Corp. Over a trading history stretching from 29 January 2016 to 28 April 2026, the count stands at 12 filings.
Purchases make up the whole of the open-market record (1 purchase, €19k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 10 share grants.
On 30 April 2026 came the latest disclosure, a share grant in HCA Healthcare, Inc. The latest purchase dates back some time: it was published 1,600 days ago, on 1 June 2022. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations